Biotech Values

[DewDiligence]

2007 Drug Sales: Innovative vs Generic,
Small Molecule vs Biologic, US vs ex-US
($B)

 
        Innovative   Generic  Innovative  Generic   All 
         small mol  small mol  biologics  biolgcs  Drugs 
 US         208         22        60        n/a     290 (44%) 
 ex-US      281         53        34         2      370 (56%) 
 =====      ===         ==        ==         =      === 
 World      489         75        94         2      660

(These figures ought to be accurate enough for investment
purposes but should not be taken as the gospel. I’ve pieced
them together from such sources as IMS estimates and
drug-company webcasts.)